# Core-005

> **NIH NIH UL1** · ROCKEFELLER UNIVERSITY · 2020 · $772,416

## Abstract

The overall goal of the Rockefeller Center for Clinical and Translational Science (CCTS) is to accelerate
translational research to improve human health and to train a workforce, including new clinical and translational
investigators, in methods, knowledge, and practices to best perform translational research. The Hub Research
Capacity Core contributes to these goals by integrating special populations into research studies and
providing participant and clinical interactions to accelerate translational research. The Core’s specific aims are:
1. To encourage the Integration of Special Populations (including children, older patients, survivors of
formerly lethal childhood diseases, minority, and underserved or health disparity populations including racial,
ethnic or gender differences as well as socio-economic status, urban environment, pregnant women, people
with disability and other “hard-to-reach” groups) in research by: a) providing a comprehensive range of
services in the new Translational Research Navigation (TRN) program to assist investigators in engaging
populations and recruiting them to studies, b) collaborating with Clinical Directors Network (CDN), a Practice
Based Research Network that serves a diverse patient population, c) collaborating with other CTSA hubs and
CDN in the NYC Clinical Data Research Network (NYC-CDRN) to build this vital database for identifying
potential participants from special populations, d) collaborating with the CTSA hubs at Vanderbilt, Scripps,
Einstein, NYU, Columbia, and Weill Cornell on a series of initiatives that are developing novel methods for
engaging special populations. 2. To enhance Participant and Clinical Interactions by: a) Initiating the
innovative multi-disciplinary Translational Research Navigation program to accelerate the development of
translational research studies and to increase access of scientists and clinicians to required regulatory
knowledge, scientifically sound study designs, appropriate methods, and needed clinical research personnel
and facilities throughout the “lifespan” of a clinical study, b) Providing system-wide oversight and monitoring to
ensure maximal integrity of research processes and participant safety, c) Using metrics to assess the success
of protocol development, implementation, progress and completion, and to drive performance improvement.
We will accomplish the first specific aim by educating investigators about the benefits of integrating special
populations into their studies and extending their research across the entire age spectrum. We will also assist
them in identifying special populations directly and via our collaboration with CDN, since the Federally
Qualified Health Center members of CDN serve a racially and ethnically diverse population of individuals,
many of whom are from medically underserved populations. We will accomplish the second specific aim by
providing a comprehensive Translational Research Navigation program that combines knowledge expert...

## Key facts

- **NIH application ID:** 10168973
- **Project number:** 5UL1TR001866-05
- **Recipient organization:** ROCKEFELLER UNIVERSITY
- **Principal Investigator:** Barry Coller
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $772,416
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10168973

## Citation

> US National Institutes of Health, RePORTER application 10168973, Core-005 (5UL1TR001866-05). Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/grant/nih/10168973. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*